PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
01-Feb-2023 PureTech to Present at the SVB Securities Global Biopharma Conference PureTech Health plc
01-Feb-2023 BioCardia and CellProthera Enhance Collaboration for Development of ProtheraCytes(TM) for the Treatment of Acute Myocardial Infarction in Europe and Potential Early Access for Patients BioCardia
01-Feb-2023 ABPI response to new MHRA fees announced for 1 April 2023 ABPI
01-Feb-2023 Pharmapack Drug Delivery Index hits record high Pharmapack
01-Feb-2023 Ellipses Pharma announces FDA approval of IND application for EP0042 for patients with acute myeloid leukaemia Ellipses Pharma
01-Feb-2023 Neuraxpharm announces closing of acquisition of established products from Sanofi Neuraxpharm
01-Feb-2023 Sequana Medical announces grant of additional DSR® patent in United States Sequana Medical
01-Feb-2023 Rare and Orphan disease expert Terebellum to launch incisive Specialty Pharmacy development bulletins, Specialty Pharmaceutical Pulse™ Terebellum
01-Feb-2023 Aptamer Group partner with BaseCure Therapeutics to develop new targeted gene therapies Aptamer Group
01-Feb-2023 X-Chem and Kymera Expand Existing Partnership X-Chem
01-Feb-2023 Coriolis Pharma Strengthens its Presence in North America by Appointing Formulation Expert Prof. Dr. Reza Nejadnik to its Scientific Advisory Board B3C newswire
01-Feb-2023 CureVac Welcomes Myriam Mendila as New Chief Development Officer CureVac
01-Feb-2023 Lausanne University Hospital Investigates Use of PENTIXAFOR in Cardio-Vascular Setting Eckert & Ziegler Strahlen- und Medizintechnik AG
01-Feb-2023 Adrenomed appoints Dr. Stephan Witte as Chief Medical Officer Adrenomed AG
31-Jan-2023 CureVac Named as One of the World’s Most Dynamic Innovators by LexisNexis® CureVac
31-Jan-2023 Biophytis publishes its financial results for the first half of 2022 Biophytis
31-Jan-2023 Defence Therapeutics Inc.: DEFENCE’S LUNG CANCER GLP TOX STUDY ON ITS INTRANASAL ACCUTOXTM FORMULATION ADVANCES Defence Therapeutics Inc.
31-Jan-2023 APONTIS PHARMA extends portfolio for the treatment of hypertension and hyperlipidemia by in-licensing a new Single Pill APONTIS PHARMA AG
30-Jan-2023 Kelso Pharma announces first product launch Kelso Pharma
30-Jan-2023 RHÖN-KLINIKUM Aktiengesellschaft: EBITDA for 2022 above the forecast range on the basis of preliminary figures RHÖN-KLINIKUM Aktiengesellschaft